Surmodics Inc (SRDX)
32.49
-2.06
(-5.96%)
USD |
NASDAQ |
May 03, 16:00
32.57
+0.08
(+0.25%)
After-Hours: 20:00
Surmodics Debt to Equity Ratio: 0.241 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.241 |
| September 30, 2023 | 0.2452 |
| June 30, 2023 | 0.2611 |
| March 31, 2023 | 0.2857 |
| December 31, 2022 | 0.275 |
| September 30, 2022 | 0.0923 |
| June 30, 2022 | 0.0799 |
| March 31, 2022 | 0.075 |
| December 31, 2021 | 0.0732 |
| September 30, 2021 | 0.0714 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.2857
Maximum
Mar 2023
0.0895
Average
0.0714
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp | 0.5327 |
| ResMed Inc | 0.2175 |
| Glaukos Corp | 0.6281 |
| Accuray Inc | 3.667 |
| Alphatec Holdings Inc | 6.565 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 180.24M |
| Total Liabilities (Quarterly) | 58.09M |
| Shareholders Equity (Quarterly) | 122.15M |
| Current Ratio | 4.844 |
| Net Debt Paydown Yield | -0.75% |